- Home
- AQST vs ABEO Comparison
AQST vs ABEO Comparison
Compare AQST & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ABEO
- Stock Information
- Founded
- AQST 2004
- ABEO N/A
- Country
- AQST United States
- ABEO United States
- Employees
- AQST N/A
- ABEO N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- AQST Health Care
- ABEO Health Care
- Exchange
- AQST Nasdaq
- ABEO Nasdaq
- Market Cap
- AQST 285.4M
- ABEO 243.9M
- IPO Year
- AQST 2018
- ABEO 1980
- Fundamental
- Price
- AQST $3.10
- ABEO $5.22
- Analyst Decision
- AQST Strong Buy
- ABEO Strong Buy
- Analyst Count
- AQST 8
- ABEO 3
- Target Price
- AQST $10.38
- ABEO $18.00
- AVG Volume (30 Days)
- AQST 1.5M
- ABEO 251.9K
- Earning Date
- AQST 03-04-2025
- ABEO 11-14-2024
- Dividend Yield
- AQST N/A
- ABEO N/A
- EPS Growth
- AQST N/A
- ABEO N/A
- EPS
- AQST N/A
- ABEO N/A
- Revenue
- AQST $58,900,000.00
- ABEO N/A
- Revenue This Year
- AQST $18.44
- ABEO N/A
- Revenue Next Year
- AQST N/A
- ABEO $18,714.71
- P/E Ratio
- AQST N/A
- ABEO N/A
- Revenue Growth
- AQST 22.56
- ABEO 147.52
- 52 Week Low
- AQST $2.24
- ABEO $3.05
- 52 Week High
- AQST $6.23
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- AQST 34.77
- ABEO 35.01
- Support Level
- AQST $2.96
- ABEO $5.05
- Resistance Level
- AQST $3.30
- ABEO $5.66
- Average True Range (ATR)
- AQST 0.21
- ABEO 0.26
- MACD
- AQST 0.01
- ABEO -0.06
- Stochastic Oscillator
- AQST 16.87
- ABEO 16.04
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.